From bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 28, 2013. For personal use only.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Analyzing the involvement of diverse cell death-related genes in diffuse large B-cell lymphoma using bioinformatics techniques

  2024cites this paper
• Advances in biology, diagnosis and treatment of DLBCL

  2024cites this paper
• Integrated Analysis of Single-Cell RNA-Seq and Bulk RNA-Seq Unravels the Molecular Feature of Tumor-Associated Macrophage of Acute Myeloid Leukemia

  2024cites this paper
• Molecular Subtypes and the Role of TP53 in Diffuse Large B-Cell Lymphoma and Richter Syndrome

  2024cites this paper
• Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL

  2024cites this paper
• Integrative genomic analysis identifies unique immune environments associated with immunotherapy response in diffuse large B cell lymphoma

  2024cites this paper
• Gene expression profiles associated with early relapse during first remission induction in canine multicentric high-grade B-cell lymphoma

  2023cites this paper
• Lymphomas in patients with neurofibromatosis type 1 (NF1): another malignancy in the NF1 syndrome?

  2023cites this paper
• Meta-Analysis of MS-Based Proteomics Studies Indicates Interferon Regulatory Factor 4 and Nucleobindin1 as Potential Prognostic and Drug Resistance Biomarkers in Diffuse Large B Cell Lymphoma

  2023cites this paper
• Genetic Profiling in Diffuse Large B Cell Lymphoma – the promise and the challenge

  2023cites this paper
• Automatic subtyping of Diffuse Large B-cell Lymphomas (DLBCL): Raman-based genetic and metabolic classification.

  2023cites this paper
• SIRT1 and HSP90α feed-forward circuit safeguards chromosome segregation integrity in diffuse large B cell lymphomas

  2023influential citation
• Oxidative stress enhances the therapeutic action of a respiratory inhibitor in MYC‐driven lymphoma

  2023cites this paper
• Molecular classification and therapeutics in diffuse large B-cell lymphoma

  2023cites this paper
• Diffuse large B-cell lymphomas have spatially defined, tumor immune microenvironments revealed by high-parameter imaging

  2023cites this paper
• The Immunology of DLBCL

  2023cites this paper
• Characterization and clinical impact of the tumor microenvironment in post-transplant aggressive B-cell lymphomas

  2023cites this paper
• Applications of Innovation Technologies for Personalized Cancer Medicine: Stem Cells and Gene-Editing Tools.

  2023cites this paper
• Application of fused graphical lasso to statistical inference for multiple sparse precision matrices

  2023cites this paper
• Development and validation of a cuproptosis-associated prognostic model for diffuse large B-cell lymphoma

  2023cites this paper
• Spleen tyrosine kinase/FMS-like tyrosine kinase-3 inhibition in relapsed/refractory B-cell lymphoma, including diffuse large B-cell lymphoma: updated data with mivavotinib (TAK-659/CB-659)

  2023cites this paper
• Metabolic Reprogramming and Potential Therapeutic Targets in Lymphoma

  2023cites this paper
• Mechanisms of ferroptosis and targeted therapeutic approaches in lymphoma

  2023cites this paper
• Multiomic Analysis Identifies a High-Risk Metabolic and TME Depleted Signature that Predicts Early Clinical Failure in DLBCL

  2023cites this paper
• The Metabolism and Immune Environment in Diffuse Large B-Cell Lymphoma

  2023cites this paper
• EGR1 changes course in B-cell lymphoma.

  2023cites this paper
• Biological heterogeneity in diffuse large B-cell lymphoma.

  2023cites this paper
• Plasma Metabolites Forecast Occurrence and Prognosis for Patients With Diffuse Large B-Cell Lymphoma

  2022cites this paper
• A comprehensive modular map of Diffuse Large B-cell Lymphoma

  2022cites this paper
• Oxidative stress potentiates the therapeutic action of a mitochondrial complex I inhibitor in MYC-driven B-cell lymphoma

  2022cites this paper
• A comprehensive modular map of Diffuse Large B-cell 1 Lymphoma 2

  2022cites this paper
• Transforming Growth Factor-Beta Orchestrates Tumour and Bystander Cells in B-Cell Non-Hodgkin Lymphoma

  2022cites this paper
• Biological and Clinical Implications of Gene-Expression Profiling in Diffuse Large B-Cell Lymphoma: A Proposal for a Targeted BLYM-777 Consortium Panel as Part of a Multilayered Analytical Approach

  2022influential citation
• Varying Coefficient Linear Discriminant Analysis for Dynamic Data

  2022cites this paper
• The identification of TCF1+ progenitor exhausted T cells in THRLBCL may predict a better response to PD-1/PD-L1 blockade

  2022cites this paper
• Diffuse large B-Cell lymphoma: from novel molecular classifications to tailored targeted therapies

  2022cites this paper
• Mitochondrial and metabolic alterations in cancer cells.

  2022cites this paper
• The Era of Genomic Research for Lymphoma: Looking Back and Forward

  2022cites this paper
• SHP1 loss augments DLBCL cellular response to ibrutinib: a candidate predictive biomarker

  2022cites this paper
• Advances in Multi-Omics Study of Prognostic Biomarkers of Diffuse Large B-Cell Lymphoma

  2022cites this paper
• Current Status of Novel Agents for the Treatment of B Cell Malignancies: What’s Coming Next?

  2022cites this paper
• Richter Syndrome: From Molecular Pathogenesis to Druggable Targets

  2022cites this paper
• Reproducibility of Gene Expression Signatures in Diffuse Large B-Cell Lymphoma

  2022influential citation
• Differential diagnosis and identification of prognostic markers for peripheral T-cell lymphoma subtypes based on flow cytometry immunophenotype profiles

  2022cites this paper
• Loss of RARRES1 function Promotes Follicular Lymphomagenesis and Inhibits B cell Differentiation in Mice

  2022cites this paper
• Mitochondrial pyruvate supports lymphoma proliferation by fueling a glutamate pyruvate transaminase 2–dependent glutaminolysis pathway

  2022influential citation
• Activity and rational combinations of a novel, engineered chimeric, TRAIL-based ligand in diffuse large B-cell lymphoma

  2022cites this paper
• Epigenetic, Metabolic, and Immune Crosstalk in Germinal-Center-Derived B-Cell Lymphomas: Unveiling New Vulnerabilities for Rational Combination Therapies

  2022cites this paper
• Advances in Understanding of Metabolism of B-Cell Lymphoma: Implications for Therapy

  2022cites this paper
• Integrated Genomic and Transcriptomic Analyses of Diffuse Large B-Cell Lymphoma With Multiple Abnormal Immunologic Markers

  2022cites this paper
• Lymphoma Microenvironment in DLBCL and PTCL-NOS: the key to uncovering heterogeneity and the potential for stratification

  2022cites this paper
• Super enhancers as master gene regulators in the pathogenesis of hematologic malignancies.

  2022cites this paper
• MYC and therapy resistance in cancer: risks and opportunities

  2022cites this paper
• Harnessing bioactive nanomaterials in modulating tumor glycolysis-associated metabolism

  2022cites this paper
• The clonal evolution of Richter transformation cells uncovers therapeutic vulnerabilities

  2022cites this paper
• Detection of early seeding of Richter transformation in chronic lymphocytic leukemia

  2022cites this paper
• Routine application of the Lymph2Cx assay for the subclassification of aggressive B-cell lymphoma: report of a prospective real-world series

  2022cites this paper
• The Alternative RelB NF-kB Subunit Exerts a Critical Survival Function upon Metabolic Stress in Diffuse Large B-Cell Lymphoma-Derived Cells

  2022cites this paper
• Gene Expression Signatures for the Accurate Diagnosis of Peripheral T-Cell Lymphoma Entities in the Routine Clinical Practice

  2022cites this paper
• Classifying Germinal Center Derived Lymphomas—Navigate a Complex Transcriptional Landscape

  2022cites this paper
• Deep learning‐based microarray cancer classification and ensemble gene selection approach

  2022cites this paper
• Germinal-Center B-Cell-Like (GCB) DLBCL Versus Activated B-Cell-Like (ABC) DLBCL: Biology and Treatment Approach

  2022cites this paper
• The path towards consensus genome classification of diffuse large B-cell lymphoma for use in clinical practice

  2022cites this paper
• Last but not least: BFL-1 as an emerging target for anti-cancer therapies

  2022cites this paper
• Autophagy and Metabolism in Normal and Malignant Hematopoiesis

  2021cites this paper
• Testicular Diffuse Large B-Cell Lymphoma—Clinical, Molecular, and Immunological Features

  2021cites this paper
• Single-cell transcriptome analysis of diffuse large B cells in cerebrospinal fluid of central nervous system lymphoma

  2021cites this paper
• Diffuse Large B-Cell Lymphoma: Recognition of Markers for Targeted Therapy

  2021cites this paper
• Metabolic Swifts Govern Normal and Malignant B Cell Lymphopoiesis

  2021influential citation
• Implication of immune cell signature of tumor microenvironment in diffuse large B‐cell lymphoma

  2021cites this paper
• Pyruvate dehydrogenase kinase 4‐mediated metabolic reprogramming is involved in rituximab resistance in diffuse large B‐cell lymphoma by affecting the expression of MS4A1/CD20

  2021cites this paper
• A graph convolutional neural network for gene expression data analysis with multiple gene networks

  2021cites this paper
• EVT‐701 is a novel selective and safe mitochondrial complex 1 inhibitor with potent anti‐tumor activity in models of solid cancers

  2021cites this paper
• Inhibitors of BCL2A1/Bfl-1 protein: Potential stock in cancer therapy.

  2021cites this paper
• Clinical significance of PD-1 and PD-L1 molecules in patients with diffuse large B-cell lymphoma, not otherwise specified: Correlation with clinical and pathological findings.

  2021cites this paper
• Correlation between circulating blood and microenvironment T lymphocytes in diffuse large B-cell lymphomas

  2021cites this paper
• A New Feature Selection and Classification Approach for Optimizing Breast Cancer Subtyping Based on Gene Expression

  2021cites this paper
• Comprehensive Characterization of Cachexia-Inducing Factors in Diffuse Large B-Cell Lymphoma Reveals a Molecular Subtype and a Prognosis-Related Signature

  2021cites this paper
• Genetic Events Inhibiting Apoptosis in Diffuse Large B Cell Lymphoma

  2021cites this paper
• Molecular classification of aggressive lymphomas—past, present, future

  2021cites this paper
• Integration of Metabolomics and Gene Expression Profiling Elucidates IL4I1 as Modulator of Ibrutinib Resistance in ABC-Diffuse Large B Cell Lymphoma

  2021cites this paper
• Clinical and biological subtypes of B-cell lymphoma revealed by microenvironmental signatures.

  2021cites this paper
• Single-cell spatial analysis of tumor immune architecture in diffuse large B-cell lymphoma

  2021cites this paper
• Understanding the Immune-Stroma Microenvironment in B Cell Malignancies for Effective Immunotherapy

  2021cites this paper
• Tumor Cells and Cancer-Associated Fibroblasts: An Updated Metabolic Perspective

  2021cites this paper
• High-Grade B-Cell Lymphoma (HGBL) with MYC and BCL2 and/or BCL6 Rearrangements Is Predominantly BCL6-Rearranged and BCL6-Expressing in Taiwan

  2021cites this paper
• Study of the antilymphoma activity of pracinostat reveals different sensitivities of DLBCL cells to HDAC inhibitors.

  2021cites this paper
• Clinical Impact of Immune Cells and Their Spatial Interactions in Diffuse Large B-Cell Lymphoma Microenvironment

  2021cites this paper
• Tomentosin a Sesquiterpene Lactone Induces Antiproliferative and Proapoptotic Effects in Human Burkitt Lymphoma by Deregulation of Anti- and Pro-Apoptotic Genes

  2021cites this paper
• NEK2 Promotes Cell Proliferation and Glycolysis by Regulating PKM2 Abundance via Phosphorylation in Diffuse Large B-Cell Lymphoma

  2021cites this paper
• Molecular Classification of Diffuse Large B-Cell Lymphoma

  2021cites this paper
• Targeting Asparagine and Serine Metabolism in Germinal Centre-Derived B Cells Non-Hodgkin Lymphomas (B-NHL)

  2021cites this paper
• Biochemistry, Pathophysiology, and Regulation of Linear Ubiquitination: Intricate Regulation by Coordinated Functions of the Associated Ligase and Deubiquitinase

  2021cites this paper
• Metabolic targeting of cancer by a ubiquinone uncompetitive inhibitor of mitochondrial complex I.

  2021cites this paper
• Metabolic Pathways in Immune Cells Commitment and Fate

  2021cites this paper
• The PD-1/PD-L1 Checkpoint in Normal Germinal Centers and Diffuse Large B-Cell Lymphomas

  2021cites this paper
• The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma.

  2021cites this paper
• Inhibition of PIM Kinases in DLBCL Targets MYC Transcriptional Program and Augments the Efficacy of Anti-CD20 Antibodies

  2021cites this paper
• Genome-wide homozygosity and risk of four non-Hodgkin lymphoma subtypes

  2021cites this paper
• Frequent mutated B2M, EZH2, IRF8, and TNFRSF14 in primary bone diffuse large B-cell lymphoma reflect a GCB phenotype.

  2021influential citation